Japan Reforms Failed To Sate U.S. Firms In 2002; EU Reuse Drive Ebbs, Wanes
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed will capitalize on new Exec. VP-Global Strategy & Analysis Marjory Searing's rapport with Japan Ministry of Health, Labor & Welfare officials to renew its assault on foreign reference pricing in 2003
You may also be interested in...
EU Anti-Reuse Drive Founders; Pharma Review Strategy Priority Heightened
European Union legislation regulating the reprocessing of single-use medical devices is unlikely, European Commission officials told Eucomed representatives Nov. 22
U.S. Device Firms Find Warmer Welcome In Japan As M&A Activity Heats Up
Boston Scientific and St. Jude are among medical device firms looking to capitalize on an improving foreign trade environment in Japan
International News In Brief
Marjory Searing: AdvaMed names former Clinton administration trade advisor VP-global strategy & analysis. Currently senior-VP at Civic Service, Inc., a Japan-focused consulting firm, Searing begins Dec. 2 at AdvaMed, where she succeeds Ed Rozynski (1"The Gray Sheet" April 19, 2002, In Brief). With 27 years of experience at the Treasury Department and Department of Commerce, including a post as deputy assistant secretary for Asia, Searing has worked on the market-oriented, sector-selective (MOSS) agreements to improve market access for medical products in Japan...